Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Visual Improvement in Bardet-Biedl Syndrome
NCT03490019Phase 2Withdrawn
- Sponsor
- University Hospital Tübingen
- Start
- Apr 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of metformin in Bardet–Biedl syndrome (BBS), sponsored by University Hospital Tübingen. Planned start Apr 2018; status: withdrawn.
02
Drugs
metformin
03
Conditions
Bardet–Biedl syndrome (BBS)
Beyond the preview
Go deeper on NCT03490019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03490019.